New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
12:38 EDTANF, RPRX, HLF, EQIX, HAINOptions with increasing implied volatility: RPRX HLF EQIX HAIN ANF
News For RPRX;HLF;EQIX;HAIN;ANF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 22, 2014
12:55 EDTHLFPivotal analyst says Herbalife 'just not a pyramid scheme'
Pivotal Research analyst Tim Ramey said on CNBC that Herbalife "is just not a pyramid scheme."
10:18 EDTHAINBoulder Brands tumbles after lowering profit outlook
Subscribe for More Information
October 21, 2014
18:36 EDTRPRXOn The Fly: After Hours Movers
Subscribe for More Information
18:33 EDTHLFIcahn reiterates view that high-yield market is a bubble
Says the Fed has given the economy, or the patient, "too much medicine." Says market should not be shorted. Again, says Apple (AAPL) CEO Tim is a "great CEO." Says Apple pay has a great future. Says Ebay (EBAY) is like his past campaign at Motorola. Reiterates view that Ebay should explore Paypal sale right now. Says Dell is on his radar screen. Says Warren Buffet sometimes too easy on companies, should do more on corporate governance. Again, says has never sold a share of Herbalife (HLF). Says Western Europe has "major problems," and continues to be short the Euro. Says energy stocks "getting cheap." Carl Icahn is speaking on Bloomberg TV.
16:11 EDTRPRXRepros Therapeutics: Results from Androxal study exhibit positive safety profile
Repros Therapeutics reported results from a large, controlled, long-term safety study comparing Androxal to a placebo. In this study of Androxal, ZA-303, no new safety signals were identified, including no evidence of negative effects on bone mineral density. Over 79% of the Androxal-treated subjects had morning testosterone levels above 300 ng/dL after being treated for 12 months. The last patient completed this study in late September. The Company's planned NDA will include study ZA-303, which will provide a significant portion of the support of long-term safety by providing data from 141 subjects exposed for one year or more. Over 200 subjects reached this milestone in the entire exposure database. ICH guidance for drugs to treat non-life-threatening conditions suggests that a minimum of 100 subjects should be exposed to the drug for one year.
October 20, 2014
11:00 EDTHLFHerbalife volatility increases
Subscribe for More Information
08:48 EDTHLFHerbalife initiated with a Buy at Pivotal Research
Subscribe for More Information
08:10 EDTEQIXHurricane Electric extends global IPv4 and IPv6 network in Asia and Europe
Subscribe for More Information
05:54 EDTHLFStocks with implied volatility movement; HLD SD
Stocks with implied volatility movement; Herbalife (HLF) 109, SandRidge Energy (SD) 97 according to iVolatility.
October 17, 2014
10:43 EDTANFUrban Outfitters slumps after warning on continued retail sales weakness
Subscribe for More Information
09:17 EDTRPRXOn The Fly: Pre-market Movers
Subscribe for More Information
October 16, 2014
20:03 EDTRPRXRepros Therapeutics upcoming meeting with FDA to be Type C, not Type B
Subscribe for More Information
17:10 EDTANFAbercrombie & Fitch, American Eagle lower after Urban Outfitters warns on sales
Subscribe for More Information
16:22 EDTEQIXEquinix declares special $416M distribution due to planned REIT conversion
Subscribe for More Information
07:41 EDTRPRXRepros Therapeutics management to meet with Brean Capital
Subscribe for More Information
October 13, 2014
12:33 EDTRPRXOptions with increasing implied volatility
Subscribe for More Information
09:23 EDTEQIXHP could buy lower valuation company, says Bernstein
Subscribe for More Information
09:01 EDTHLFHerbalife moving distributor websites to central control, NY Post reports
Subscribe for More Information
October 10, 2014
12:11 EDTHLFOptions with increasing implied volatility
Subscribe for More Information
10:55 EDTHLFHerbalife volatility increases
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use